Johannes Levin
Johannes Levin
Professor für Neurologie, Ludwig-Maximilians-Universität München; CMO MODAG GmbH
Verified email at
Cited by
Cited by
Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria
GU Höglinger, G Respondek, M Stamelou, C Kurz, KA Josephs, AE Lang, ...
Movement Disorders 32 (6), 853-864, 2017
Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer’s disease
O Preische, SA Schultz, A Apel, J Kuhle, SA Kaeser, C Barro, S Gräber, ...
Nature medicine 25 (2), 277-283, 2019
Hough-CNN: deep learning for segmentation of deep brain regions in MRI and ultrasound
F Milletari, SA Ahmadi, C Kroll, A Plate, V Rozanski, J Maiostre, J Levin, ...
Computer Vision and Image Understanding 164, 92-102, 2017
Anle138b: a novel oligomer modulator for disease-modifying therapy of neurodegenerative diseases such as prion and Parkinson’s disease
J Wagner, S Ryazanov, A Leonov, J Levin, S Shi, F Schmidt, C Prix, ...
Acta neuropathologica 125 (6), 795-813, 2013
Single particle characterization of iron-induced pore-forming α-synuclein oligomers
M Kostka, T Högen, KM Danzer, J Levin, M Habeck, A Wirth, R Wagner, ...
Journal of Biological Chemistry 283 (16), 10992-11003, 2008
Inhibition and disaggregation of α-synuclein oligomers by natural polyphenolic compounds
M Caruana, T Högen, J Levin, A Hillmer, A Giese, N Vassallo
FEBS letters 585 (8), 1113-1120, 2011
Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer's disease: a longitudinal study
BA Gordon, TM Blazey, Y Su, A Hari-Raj, A Dincer, S Flores, ...
The Lancet Neurology 17 (3), 241-250, 2018
Early changes in CSF sTREM2 in dominantly inherited Alzheimer’s disease occur after amyloid deposition and neuronal injury
M Suárez-Calvet, MÁA Caballero, G Kleinberger, RJ Bateman, AM Fagan, ...
Science translational medicine 8 (369), 369ra178-369ra178, 2016
First symptom in sporadic Creutzfeldt–Jakob disease
GD Rabinovici, PN Wang, J Levin, L Cook, M Pravdin, J Davis, ...
Neurology 66 (2), 286-287, 2006
Effect of metal ions on de novo aggregation of full-length prion protein
A Giese, J Levin, U Bertsch, H Kretzschmar
Biochemical and biophysical research communications 320 (4), 1240-1246, 2004
The differential diagnosis and treatment of atypical parkinsonism
J Levin, A Kurz, T Arzberger, A Giese, GU Höglinger
Deutsches Ärzteblatt International 113 (5), 61, 2016
Extracellular vesicle sorting of α-Synuclein is regulated by sumoylation
M Kunadt, K Eckermann, A Stuendl, J Gong, B Russo, K Strauss, S Rai, ...
Acta neuropathologica 129 (5), 695-713, 2015
Longitudinal cognitive and biomarker changes in dominantly inherited Alzheimer disease
E McDade, G Wang, BA Gordon, J Hassenstab, TLS Benzinger, V Buckles, ...
Neurology 91 (14), e1295-e1306, 2018
A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer’s disease
NR Barthélemy, Y Li, N Joseph-Mathurin, BA Gordon, J Hassenstab, ...
Nature medicine 26 (3), 398-407, 2020
Which ante mortem clinical features predict progressive supranuclear palsy pathology?
G Respondek, C Kurz, T Arzberger, Y Compta, E Englund, LW Ferguson, ...
Movement Disorders 32 (7), 995-1005, 2017
slan-defined subsets of CD16-positive monocytes: impact of granulomatous inflammation and M-CSF receptor mutation
TP Hofer, AM Zawada, M Frankenberger, K Skokann, AA Satzl, ...
Blood 126 (24), 2601-2610, 2015
Increased α-synuclein aggregation following limited cleavage by certain matrix metalloproteinases
J Levin, A Giese, K Boetzel, L Israel, T Högen, G Nübling, H Kretzschmar, ...
Experimental neurology 215 (1), 201-208, 2009
Behavioural outcomes of subthalamic stimulation and medical therapy versus medical therapy alone for Parkinson's disease with early motor complications (EARLYSTIM trial …
E Lhommée, L Wojtecki, V Czernecki, K Witt, F Maier, L Tonder, ...
The Lancet Neurology 17 (3), 223-231, 2018
Single-channel electrophysiology reveals a distinct and uniform pore complex formed by α-synuclein oligomers in lipid membranes
F Schmidt, J Levin, F Kamp, H Kretzschmar, A Giese, K Bötzel
PloS one 7 (8), e42545, 2012
The oligomer modulator anle138b inhibits disease progression in a Parkinson mouse model even with treatment started after disease onset
J Levin, F Schmidt, C Boehm, C Prix, K Bötzel, S Ryazanov, A Leonov, ...
Acta neuropathologica 127 (5), 779-780, 2014
The system can't perform the operation now. Try again later.
Articles 1–20